Cleared Traditional

K061463 - ESOPHAGEAL MAPPING CATHETER

K061463 is the FDA 510(k) clearance for ESOPHAGEAL MAPPING CATHETER by Biosense Webster, Inc.. It is a Class 2 Cardiovascular device (product code DRF) cleared through the Traditional 510(k) pathway after a 80-day FDA review.

K061463 · Biosense Webster, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2006
Decision
80d
Days
Class 2
Risk

K061463 is an FDA 510(k) clearance for the ESOPHAGEAL MAPPING CATHETER, MODEL D-1272-01-S. Classified as Catheter, Electrode Recording, Or Probe, Electrode Recording (product code DRF), Class II - Special Controls.

Submitted by Biosense Webster, Inc. (Diamond Bar, US). The FDA issued a Cleared decision on August 14, 2006 after a review of 80 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1220 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Biosense Webster, Inc. devices

Submission Details

510(k) Number K061463 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 26, 2006
Decision Date August 14, 2006
Days to Decision 80 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
45d faster than avg
Panel avg: 125d · This submission: 80d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DRF Catheter, Electrode Recording, Or Probe, Electrode Recording
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DRF Catheter, Electrode Recording, Or Probe, Electrode Recording

All 96
Devices cleared under the same product code (DRF) and FDA review panel - the closest regulatory comparables to K061463.
CS REFSTAR CATHETER (D- AND F-CURVES), MODELS D-1285-01 AND D-1285-02
K080425 · Biosense Webster, Inc. · Apr 2008
REFLEXION SPIRAL VARIABLE RADIUS CATHETER
K072012 · St Jude Medical · Aug 2007
REFLEXION SPIRAL VARIABLE RADIUS CATHETER, MODEL 402804
K062251 · St Jude Medical · Oct 2006
REFSTAR EXTERNAL REFERENCE PATCH
K061468 · Biosense Webster, Inc. · Aug 2006
CARTO RMT EP NAVIGATION SYSTEM V8
K060047 · Biosense Webster, Inc. · Jun 2006
REFSTAR RMT EXTERNAL REFERENCE PATCH
K042998 · Biosense Webster, Inc. · Sep 2005